Olanzapine And Fluoxetine Capsule
Product Images NDC 49884-253
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Olanzapine And Fluoxetine (NDC 49884-253). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Olanzapine And Fluoxetine Capsules 10
Olanzapine And Fluoxetine Capsules 11
Olanzapine And Fluoxetine Capsules 12
Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Relapse (Olanzapine And Fluoxetine Capsules 2)
3mg/25mg (30 capsules)
6mg/25mg (30 capsules)
6mg/50mg (30 capsules)
12mg/25mg (30 capsules)
12mg/50mg (30 capsules)
Olanzapine And Fluoxetine Capsules 8
Olanzapine And Fluoxetine Capsules 9
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.